Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glycine-gated chloride ion channel activity	GLRA3 GLRA2	3.29e-05	2	115	2	GO:0022852
GeneOntologyMolecularFunction	glycine binding	GLRA3 GLDC GLRA2	6.47e-05	14	115	3	GO:0016594
GeneOntologyCellularComponent	septin complex	SEPTIN6 SEPTIN8 SEPTIN11	5.50e-05	14	114	3	GO:0031105
GeneOntologyCellularComponent	septin ring	SEPTIN6 SEPTIN8 SEPTIN11	5.50e-05	14	114	3	GO:0005940
GeneOntologyCellularComponent	septin cytoskeleton	SEPTIN6 SEPTIN8 SEPTIN11	8.40e-05	16	114	3	GO:0032156
Domain	G_SEPTIN_dom	SEPTIN6 SEPTIN8 SEPTIN11	5.75e-05	13	112	3	IPR030379
Domain	Septin	SEPTIN6 SEPTIN8 SEPTIN11	5.75e-05	13	112	3	PF00735
Domain	G_SEPTIN	SEPTIN6 SEPTIN8 SEPTIN11	5.75e-05	13	112	3	PS51719
Domain	KRAB	ZNF585A ZNF175 ZNF254 ZNF195 ZNF621 ZNF595 ZNF436 ZNF92 ZNF84 ZNF90	5.91e-05	358	112	10	PS50805
Domain	KRAB	ZNF585A ZNF175 ZNF254 ZNF195 ZNF621 ZNF595 ZNF436 ZNF92 ZNF84 ZNF90	5.91e-05	358	112	10	PF01352
Domain	zf-C2H2	ZNF138 ZNF585A FEZF2 ZNF175 ZNF254 ZNF195 ZNF621 ZNF595 GFI1 ZNF691 ZNF436 ZNF92 ZNF84 ZNF90	6.86e-05	693	112	14	PF00096
Domain	Septin	SEPTIN6 SEPTIN8 SEPTIN11	7.28e-05	14	112	3	IPR016491
Domain	KRAB	ZNF585A ZNF175 ZNF254 ZNF195 ZNF621 ZNF595 ZNF436 ZNF92 ZNF84 ZNF90	7.60e-05	369	112	10	SM00349
Domain	KRAB	ZNF585A ZNF175 ZNF254 ZNF195 ZNF621 ZNF595 ZNF436 ZNF92 ZNF84 ZNF90	7.77e-05	370	112	10	IPR001909
Domain	Glycine_rcpt_A	GLRA3 GLRA2	2.12e-04	4	112	2	IPR008127
Domain	-	ZNF138 ZNF585A FEZF2 ZNF175 ZNF254 ZNF195 ZNF621 GFI1 ZNF691 ZNF436 ZNF92 ZNF84 ZNF90	2.15e-04	679	112	13	3.30.160.60
Domain	ZINC_FINGER_C2H2_2	ZNF138 ZNF585A FEZF2 ZNF175 ZNF254 ZNF195 ZNF621 ZNF595 GFI1 ZNF691 ZNF436 ZNF92 ZNF84 ZNF90	2.21e-04	775	112	14	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF138 ZNF585A FEZF2 ZNF175 ZNF254 ZNF195 ZNF621 ZNF595 GFI1 ZNF691 ZNF436 ZNF92 ZNF84 ZNF90	2.27e-04	777	112	14	PS00028
Domain	Znf_C2H2/integrase_DNA-bd	ZNF138 ZNF585A FEZF2 ZNF175 ZNF254 ZNF195 ZNF621 GFI1 ZNF691 ZNF436 ZNF92 ZNF84 ZNF90	2.66e-04	694	112	13	IPR013087
Domain	Znf_C2H2	ZNF138 ZNF585A FEZF2 ZNF175 ZNF254 ZNF195 ZNF621 ZNF595 GFI1 ZNF691 ZNF436 ZNF92 ZNF84 ZNF90	3.26e-04	805	112	14	IPR007087
Domain	ZnF_C2H2	ZNF138 ZNF585A FEZF2 ZNF175 ZNF254 ZNF195 ZNF621 ZNF595 GFI1 ZNF691 ZNF436 ZNF92 ZNF84 ZNF90	3.38e-04	808	112	14	SM00355
Domain	FATC	ATR MTOR	3.52e-04	5	112	2	PF02260
Domain	FAT	ATR MTOR	5.26e-04	6	112	2	PS51189
Domain	FATC	ATR MTOR	5.26e-04	6	112	2	PS51190
Domain	FAT	ATR MTOR	5.26e-04	6	112	2	PF02259
Domain	PIK-rel_kinase_FAT	ATR MTOR	5.26e-04	6	112	2	IPR003151
Domain	FATC_dom	ATR MTOR	5.26e-04	6	112	2	IPR003152
Domain	PIK_FAT	ATR MTOR	5.26e-04	6	112	2	IPR014009
Domain	FATC	ATR MTOR	5.26e-04	6	112	2	SM01343
Domain	Znf_MYM	ZMYM4 ZMYM6	7.34e-04	7	112	2	IPR010507
Domain	zf-FCS	ZMYM4 ZMYM6	7.34e-04	7	112	2	PF06467
Domain	Znf_C2H2-like	ZNF138 ZNF585A FEZF2 ZNF175 ZNF254 ZNF195 ZNF621 GFI1 ZNF691 ZNF436 ZNF92 ZNF84 ZNF90	9.63e-04	796	112	13	IPR015880
Domain	TRASH_dom	ZMYM4 ZMYM6	9.75e-04	8	112	2	IPR011017
Domain	TRASH	ZMYM4 ZMYM6	9.75e-04	8	112	2	SM00746
Domain	EPL1	JADE1 EPC1	9.75e-04	8	112	2	PF10513
Domain	Enhancer_polycomb-like_N	JADE1 EPC1	9.75e-04	8	112	2	IPR019542
Domain	Myosin_head_motor_dom	MYO1D MYO10 MYO18B	1.52e-03	38	112	3	IPR001609
Domain	MYOSIN_MOTOR	MYO1D MYO10 MYO18B	1.52e-03	38	112	3	PS51456
Domain	Myosin_head	MYO1D MYO10 MYO18B	1.52e-03	38	112	3	PF00063
Domain	MYSc	MYO1D MYO10 MYO18B	1.52e-03	38	112	3	SM00242
Domain	zf-C2H2_6	FEZF2 ZNF195 ZNF621 GFI1 ZNF92 ZNF84 ZNF90	2.86e-03	314	112	7	PF13912
Domain	PI3/4_kinase_CS	ATR MTOR	3.56e-03	15	112	2	IPR018936
Domain	-	ATR MTOR	4.05e-03	16	112	2	1.10.1070.11
Domain	PI3Kc	ATR MTOR	4.05e-03	16	112	2	SM00146
Domain	HEAT	ATR TOGARAM1 MTOR	5.10e-03	58	112	3	IPR000357
Domain	PI3_PI4_kinase	ATR MTOR	5.12e-03	18	112	2	PF00454
Domain	PI3_4_KINASE_1	ATR MTOR	5.12e-03	18	112	2	PS00915
Domain	PI3_4_KINASE_2	ATR MTOR	5.12e-03	18	112	2	PS00916
Domain	PI3/4_kinase_cat_dom	ATR MTOR	5.12e-03	18	112	2	IPR000403
Domain	PI3_4_KINASE_3	ATR MTOR	5.12e-03	18	112	2	PS50290
Pubmed	SOX5 controls the sequential generation of distinct corticofugal neuron subtypes.	RELN CRIM1 FEZF2 DIAPH3	1.56e-07	15	116	4	18215621
Pubmed	Comparative analysis of KRAB zinc finger proteins in rodents and man: evidence for several evolutionarily distinct subfamilies of KRAB zinc finger genes.	ZNF254 ZNF195 ZNF595	2.99e-06	9	116	3	10360839
Pubmed	Superfluous role of mammalian septins 3 and 5 in neuronal development and synaptic transmission.	SEPTIN6 SEPTIN8 SEPTIN11	2.99e-06	9	116	3	18809578
Pubmed	Cyclooxygenase-2 up-regulates ataxia telangiectasia and Rad3 related through extracellular signal-regulated kinase activation.	ATR PTGS2	1.10e-05	2	116	2	19584262
Pubmed	Electrophysiological Signature of Homomeric and Heteromeric Glycine Receptor Channels.	GLRA3 GLRA2	1.10e-05	2	116	2	27382060
Pubmed	Inhibition of mammalian target of rapamycin signaling pathway decreases retinoic acid stimulated gene 8 expression in adult mouse testis.	STRA8 MTOR	1.10e-05	2	116	2	25241363
Pubmed	mTOR-dependent regulation of PHLPP expression controls the rapamycin sensitivity in cancer cells.	MTOR PHLPP1	1.10e-05	2	116	2	21177869
Pubmed	Selective glycine receptor α2 subunit control of crossover inhibition between the on and off retinal pathways.	GLRA3 GLRA2	1.10e-05	2	116	2	22399754
Pubmed	ATR-dependent phosphorylation of FANCM at serine 1045 is essential for FANCM functions.	ATR FANCM	1.10e-05	2	116	2	23698467
Pubmed	Mannan and peptidoglycan induce COX-2 protein in human PMN via the mammalian target of rapamycin.	PTGS2 MTOR	1.10e-05	2	116	2	17683115
Pubmed	Knockdown of REV3 synergizes with ATR inhibition to promote apoptosis induced by cisplatin in lung cancer cells.	ATR REV3L	1.10e-05	2	116	2	28075014
Pubmed	MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.	MTOR MYO18B	1.10e-05	2	116	2	30390677
Pubmed	Glycine receptor α3 and α2 subunits mediate tonic and exogenous agonist-induced currents in forebrain.	GLRA3 GLRA2	1.10e-05	2	116	2	28784756
Pubmed	Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo.	CRIM1 FEZF2 DIAPH3	1.28e-05	14	116	3	15664173
Pubmed	The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features.	ATR FANCM FANCI	1.60e-05	15	116	3	19536649
Pubmed	Localization of septin proteins in the mouse cochlea.	SEPTIN6 SEPTIN8 SEPTIN11	1.96e-05	16	116	3	22575789
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	AHCYL1 PDE2A FAM120B MYO1D COPS3 PTGS2 OPCML SEPTIN6 CSDE1 SEPTIN8 ATP6V1H MICAL2 SEPTIN11 ATP1A2 TNS1 VDAC1	2.23e-05	1431	116	16	37142655
Pubmed	Fezl is required for the birth and specification of corticospinal motor neurons.	CRIM1 FEZF2 DIAPH3	2.38e-05	17	116	3	16157277
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	AHCYL1 DTNA SEC24A SMC2 CSDE1 ATP6V1H CCDC88A FANCI DIAPH3 SLC25A19 VDAC1	2.62e-05	708	116	11	39231216
Pubmed	The granulocyte-colony stimulating factor receptor (G-CSFR) interacts with retinoic acid receptors (RARs) in the regulation of myeloid differentiation.	RARA CSF3R	3.30e-05	3	116	2	23136256
Pubmed	The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling.	RARA PRAME	3.30e-05	3	116	2	16179254
Pubmed	The interleukin 6 trans-signaling increases prostaglandin E2 production in human granulosa cells†.	PTGS2 IL6R	3.30e-05	3	116	2	34198336
Pubmed	Cloning and mapping of members of the MYM family.	ZMYM4 ZMYM6	3.30e-05	3	116	2	10486218
Pubmed	F-actin rearrangement is regulated by mTORC2/Akt/Girdin in mouse fertilized eggs.	CCDC88A MTOR	3.30e-05	3	116	2	27666957
Pubmed	Remodeling of Interstrand Crosslink Proximal Replisomes Is Dependent on ATR, FANCM, and FANCD2.	ATR FANCM	3.30e-05	3	116	2	31067464
Pubmed	Human endothelial cell septins: SEPT11 is an interaction partner of SEPT5.	SEPTIN8 SEPTIN11	3.30e-05	3	116	2	16767699
Pubmed	Voriconazole-induced photocarcinogenesis is promoted by aryl hydrocarbon receptor-dependent COX-2 upregulation.	PTGS2 ARNT	3.30e-05	3	116	2	29568008
Pubmed	Interleukin 6 receptor alpha expression in PMNs isolated from prematurely born neonates: decreased expression is associated with differential mTOR signaling.	MTOR IL6R	3.30e-05	3	116	2	30965356
Pubmed	Glycinergic input of small-field amacrine cells in the retinas of wildtype and glycine receptor deficient mice.	GLRA3 GLRA2	3.30e-05	3	116	2	17920294
Pubmed	Septin expression in proliferative retinal membranes.	SEPTIN8 SEPTIN11	3.30e-05	3	116	2	17625225
Pubmed	The ATM and ATR kinases regulate centrosome clustering and tumor recurrence by targeting KIFC1 phosphorylation.	ATR KIFC1	3.30e-05	3	116	2	33397932
Pubmed	Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells.	MTOR VDAC1	3.30e-05	3	116	2	26655341
Pubmed	Regulation of the Fanconi Anemia DNA Repair Pathway by Phosphorylation and Monoubiquitination.	ATR FANCI	3.30e-05	3	116	2	34828369
Pubmed	Developmental expression pattern of Stra6, a retinoic acid-responsive gene encoding a new type of membrane protein.	RARA STRA8	3.30e-05	3	116	2	9203140
Pubmed	Direct control of mitochondrial function by mTOR.	MTOR VDAC1	3.30e-05	3	116	2	20080789
Pubmed	Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR).	MTOR IL6R	3.30e-05	3	116	2	24047696
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF195 ZNF595 ZNF92 ZNF724 ZNF84 ZNF90	3.38e-05	181	116	6	37372979
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	AHCYL1 MYO10 INTS1 TRMT1 JADE1 GFI1 ARNT SUDS3 EPC1 CDK5RAP1 PHLPP1 DIAPH3 NXF1 ZMYM4 VDAC1	3.64e-05	1327	116	15	32694731
Pubmed	Emergence of the ZNF91 Krüppel-associated box-containing zinc finger gene family in the last common ancestor of anthropoidea.	ZNF254 ZNF195 ZNF595	3.95e-05	20	116	3	7479878
Pubmed	Activation of the c-H-ras proto-oncogene by retrovirus insertion and chromosomal rearrangement in a Moloney leukemia virus-induced T-cell leukemia.	ZNF254 ZNF195 ZNF595	3.95e-05	20	116	3	2542606
Pubmed	Chromosomal location of fifteen unique mouse KRAB-containing zinc finger loci.	ZNF254 ZNF195 ZNF595 CSF3R	5.29e-05	61	116	4	8662221
Pubmed	Proteomic Analysis of the Spinophilin Interactome in Rodent Striatum Following Psychostimulant Sensitization.	AHCYL1 OPCML SEPTIN6 SEPTIN8 ATP6V1H SEPTIN11 ATP1A2 VDAC1	6.48e-05	403	116	8	30562941
Pubmed	Expression and mRNA splicing of glycine receptor subunits and gephyrin during neuronal differentiation of P19 cells in vitro, studied by RT-PCR and immunocytochemistry.	GLRA3 GLRA2	6.59e-05	4	116	2	9051263
Pubmed	CCR5-Dependent Activation of mTORC1 Regulates Translation of Inducible NO Synthase and COX-2 during Encephalomyocarditis Virus Infection.	PTGS2 MTOR	6.59e-05	4	116	2	26408666
Pubmed	Quantitative nuclear proteomics identifies mTOR regulation of DNA damage response.	ATR MTOR	6.59e-05	4	116	2	19955088
Pubmed	Epidermal growth factor-activated aryl hydrocarbon receptor nuclear translocator/HIF-1{beta} signal pathway up-regulates cyclooxygenase-2 gene expression associated with squamous cell carcinoma.	PTGS2 ARNT	6.59e-05	4	116	2	19203995
Pubmed	Corticospinal neuron subpopulation-specific developmental genes prospectively indicate mature segmentally specific axon projection targeting.	CRIM1 FEZF2	6.59e-05	4	116	2	34686320
Pubmed	Neutrophils control the magnitude and spread of the immune response in a thromboxane A2-mediated process.	PTGS2 CSF3R	6.59e-05	4	116	2	23337807
Pubmed	Glycinergic input of widefield, displaced amacrine cells of the mouse retina.	GLRA3 GLRA2	6.59e-05	4	116	2	19528249
Pubmed	Activation of glycine receptor phase-shifts the circadian rhythm in neuronal activity in the mouse suprachiasmatic nucleus.	GLRA3 GLRA2	6.59e-05	4	116	2	21486797
Pubmed	Fine mapping of the human pentraxin gene region on chromosome 1q23.	PTGS2 FCER1A	6.59e-05	4	116	2	8613143
Pubmed	FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway.	ATR FANCI	6.59e-05	4	116	2	18931676
Pubmed	Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.	FANCM FANCI	6.59e-05	4	116	2	19737859
Pubmed	Human transcription factor protein interaction networks.	AHCYL1 MYO1D DTNA SEC24A ZNF691 SEPTIN6 ARNT SUDS3 EPC1 ZNF724 HERC1 NXF1 ZMYM4 VDAC1 KIFC1	8.37e-05	1429	116	15	35140242
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	AHCYL1 RELN PDE2A CRIM1 FEZF2 REV3L SMYD2 CSDE1 MICAL2 ZNF92 ZNF84 ATP1A2 ZMYM4 DOP1B	9.95e-05	1285	116	14	35914814
Pubmed	5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia.	ATR MTOR EXOC2	9.97e-05	27	116	3	23027611
Pubmed	Septins regulate bacterial entry into host cells.	SEPTIN6 SEPTIN11	1.10e-04	5	116	2	19145258
Pubmed	Developmental regulation of glycine receptors at efferent synapses of the murine cochlea.	GLRA3 GLRA2	1.10e-04	5	116	2	21850450
Pubmed	Native glycine receptor subtypes and their physiological roles.	GLRA3 GLRA2	1.10e-04	5	116	2	18721822
Pubmed	ATR-mediated phosphorylation of FANCI regulates dormant origin firing in response to replication stress.	ATR FANCI	1.10e-04	5	116	2	25843623
Pubmed	Septins promote dendrite and axon development by negatively regulating microtubule stability via HDAC6-mediated deacetylation.	SEPTIN6 SEPTIN11	1.10e-04	5	116	2	24113571
Pubmed	Inter-axonal molecular crosstalk via Lumican proteoglycan sculpts murine cervical corticospinal innervation by distinct subpopulations.	CRIM1 FEZF2	1.10e-04	5	116	2	36934325
Pubmed	Genetic control of neutrophil superoxide production in diabetes-resistant ALR/Lt mice.	ARNT IL6R	1.10e-04	5	116	2	11937300
Pubmed	Pyramidal neuron subtype diversity governs microglia states in the neocortex.	RELN FEZF2	1.10e-04	5	116	2	35948630
Pubmed	The KRAB zinc finger protein RSL1 modulates sex-biased gene expression in liver and adipose tissue to maintain metabolic homeostasis.	ZNF254 ZNF595	1.10e-04	5	116	2	24190968
Pubmed	A pair of mouse KRAB zinc finger proteins modulates multiple indicators of female reproduction.	ZNF254 ZNF595	1.10e-04	5	116	2	20042539
Pubmed	mTOR regulates lysosomal ATP-sensitive two-pore Na(+) channels to adapt to metabolic state.	LAMP1 MTOR	1.10e-04	5	116	2	23394946
Pubmed	Regulator of sex-limitation (Rsl) encodes a pair of KRAB zinc-finger genes that control sexually dimorphic liver gene expression.	ZNF254 ZNF195 ZNF595	1.24e-04	29	116	3	14563677
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	MYO1D SEC24A TRMT1 CHML PIGU SENP1 STX5 PMPCA ARFGAP3 CDK5RAP1 PNPLA8 DIAPH3 HERC1 PRAME VDAC1	1.39e-04	1496	116	15	32877691
Pubmed	SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice.	INTS1 REV3L SMC2 ZMYM4 VDAC1	1.52e-04	150	116	5	30154076
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MYO1D DTNA ARNT CCDC88A ZNF92 DIAPH3 NXF1 ZMYM4 ZMYM6	1.63e-04	588	116	9	38580884
Pubmed	FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex.	ATR FANCM	1.64e-04	6	116	2	18995830
Pubmed	PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.	ARNT MTOR	1.64e-04	6	116	2	23183047
Pubmed	ATR-ATRIP kinase complex triggers activation of the Fanconi anemia DNA repair pathway.	ATR FANCI	1.64e-04	6	116	2	22258451
Pubmed	FANCI is a negative regulator of Akt activation.	FANCI PHLPP1	1.64e-04	6	116	2	27097374
Pubmed	The KRAB-zinc-finger protein ZFP708 mediates epigenetic repression at RMER19B retrotransposons.	ZNF254 ZNF595	1.64e-04	6	116	2	30846446
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	AHCYL1 CRIM1 ATR INTS1 PIGU CSDE1 SEPTIN8 STX5 PMPCA FANCI SEPTIN11 HERC1	2.29e-04	1061	116	12	33845483
Pubmed	The KRAB zinc finger protein RSL1 regulates sex- and tissue-specific promoter methylation and dynamic hormone-responsive chromatin configuration.	ZNF254 ZNF595	2.29e-04	7	116	2	22801370
Pubmed	Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth.	RELN MTOR	2.29e-04	7	116	2	17698586
Pubmed	Cbln1 Directs Axon Targeting by Corticospinal Neurons Specifically toward Thoraco-Lumbar Spinal Cord.	CRIM1 FEZF2	2.29e-04	7	116	2	36823038
Pubmed	Glycine receptors support excitatory neurotransmitter release in developing mouse visual cortex.	GLRA3 GLRA2	2.29e-04	7	116	2	22988142
Pubmed	Lysosomal dynamics regulate mammalian cortical neurogenesis.	LAMP1 MTOR	2.29e-04	7	116	2	38103552
Pubmed	The carboxyl terminus of FANCE recruits FANCD2 to the Fanconi Anemia (FA) E3 ligase complex to promote the FA DNA repair pathway.	FANCM FANCI	2.29e-04	7	116	2	24451376
Pubmed	Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in NRF2 activation via BACH1 repressor turnover.	AHCYL1 FBXL2 PRAME	2.38e-04	36	116	3	24035498
Pubmed	Septin 14 is involved in cortical neuronal migration via interaction with Septin 4.	SEPTIN6 SEPTIN11	3.05e-04	8	116	2	20181826
Pubmed	Identifying key genes related to inflammasome in severe COVID-19 patients based on a joint model with random forest and artificial neural network.	PTGS2 MTOR	3.05e-04	8	116	2	37113134
Pubmed	The evolutionarily conserved Krüppel-associated box domain defines a subfamily of eukaryotic multifingered proteins.	ZNF92 ZNF90	3.05e-04	8	116	2	2023909
Pubmed	A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability.	ATR MTOR	3.05e-04	8	116	2	20810650
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	AHCYL1 ATR SMC2 CSDE1 ARNT CCDC88A CDK5RAP1 NXF1 KIFC1	3.40e-04	650	116	9	38777146
Pubmed	Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation.	TRMT1 SEPTIN6 CSDE1 SEPTIN8 SEPTIN11	3.54e-04	180	116	5	30110629
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	MYO1D MYO10 MICAL2 ATP1A2	3.74e-04	101	116	4	9872452
Pubmed	ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.	JADE1 SUDS3 EPC1	3.77e-04	42	116	3	16387653
Pubmed	Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.	ATR SMC2 ATP6V1H MTOR DOP1B	3.82e-04	183	116	5	23956138
Pubmed	The ubiquitin- and proteasome-dependent degradation of COX-2 is regulated by the COP9 signalosome and differentially influenced by coxibs.	COPS3 PTGS2	3.91e-04	9	116	2	17429597
Pubmed	Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.	LAMP1 MTOR	3.91e-04	9	116	2	28137967
Pubmed	A 6000 kb segment of chromosome 1 is conserved in human and mouse.	FCER1A ATP1A2	3.91e-04	9	116	2	2591369
Pubmed	Retinoid signaling determines germ cell fate in mice.	RARA STRA8	3.91e-04	9	116	2	16574820
Pubmed	FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women.	RELN FBXO10	3.91e-04	9	116	2	20554749
Pubmed	The epigenetic modifications and the anterior to posterior characterization of meiotic entry during mouse oogenesis.	RARA STRA8	3.91e-04	9	116	2	28235998
Pubmed	Physical and genetic linkage of the genes encoding Ly-9 and CD48 on mouse and human chromosomes 1.	FCER1A ATP1A2	3.91e-04	9	116	2	7797269
Interaction	FGFR1 interactions	AHCYL1 RARA DTNA SEC24A SMC2 OPCML SEPTIN6 SEPTIN8 CCDC88A STX5 ARFGAP3 FANCI SEPTIN11 IL17RD VDAC1	2.50e-06	632	113	15	int:FGFR1
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF138 ZNF585A FEZF2 ZNF175 ZNF254 ZNF195 ZNF621 ZNF595 GFI1 ZNF691 ZNF436 ZNF92 ZNF84 ZNF90	7.87e-06	718	87	14	28
GeneFamily	Septins	SEPTIN6 SEPTIN8 SEPTIN11	2.97e-05	13	87	3	732
GeneFamily	Glycine receptors	GLRA3 GLRA2	2.27e-04	5	87	2	868
GeneFamily	Zinc fingers MYM-type	ZMYM4 ZMYM6	3.39e-04	6	87	2	86
GeneFamily	X-linked mental retardation\|RNA helicases	FANCM HFM1	1.22e-03	11	87	2	1168
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	FANCM FANCI	4.11e-03	20	87	2	548
ToppCell	10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic\|bone_marrow / Manually curated celltypes from each tissue	SMC2 FCER1A FANCI HFM1 DIAPH3 ATP1A2 KIFC1	5.67e-07	185	116	7	9d3168c7f0b1d739f78b368969cf5c77ce202b97
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	OPCML GLRA2 MYO18B PRAME UBALD1	4.07e-06	91	116	5	b0658e020f80e56fab9d2aa07e321d9b33d7af2c
ToppCell	normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs\|normal_Lymph_Node / Location, Cell class and cell subclass	ATP8B3 CLEC5A PTGS2 CC2D2B FCER1A CSF3R	6.20e-06	173	116	6	38f88f5bbf92a3bf5109bc4782cd071b7cb1ca34
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CLEC9A DTNA PTGS2 CCDC88A CSF3R NALCN	1.03e-05	189	116	6	e4b2f00cb3675a4d94e8807d6ff99cc55f9ed233
ToppCell	Monocytes-Tissue-resident_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	CLEC9A DTNA CLEC5A FCER1A CSF3R ALPK3	1.16e-05	193	116	6	198552810dcac8d0ca63a78badd6702b49ff6edf
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SMC2 OPCML FANCI ZNF724 DIAPH3 KIFC1	1.16e-05	193	116	6	bbdfda6665941cfa1965418bb91ef9ff43b1326f
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1\|TCGA-Endometrium / Sample_Type by Project: Shred V9	SMC2 PTGS2 SMYD2 FANCI DIAPH3 IL17RD	1.16e-05	193	116	6	c2673d86f7d7b849788036032a93a6d136a70040
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-conventional_dendritic_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CLEC9A DTNA CCDC88A FCER1A IL6R VDAC1	1.16e-05	193	116	6	984ea5b871479527ab57dd813bacae844c0d8c06
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-conventional_dendritic_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CLEC9A DTNA CCDC88A FCER1A IL6R VDAC1	1.16e-05	193	116	6	529281b912070c8655e38880ac73f5e4bd6ee4ce
ToppCell	ILEUM-inflamed-(3)_moDC\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CLEC9A CHML PTGS2 CCDC88A FCER1A CSF3R	1.19e-05	194	116	6	c9d2acab0bbcfa9a9113cf3b9f8147403f0beb43
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CRIM1 MYO1D DTNA MICAL2 ATP1A2 MYO18B	1.19e-05	194	116	6	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CRIM1 MYO1D DTNA MICAL2 ATP1A2 MYO18B	1.19e-05	194	116	6	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_1\|343B / Donor, Lineage, Cell class and subclass (all cells)	CLEC5A SMC2 FCER1A FANCI DIAPH3 KIFC1	1.23e-05	195	116	6	47a01b8a92eebeb34ac7f70bf1ab4613a326e24f
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	RELN PDE2A CRIM1 MYO10 ADGRL4 HERC1	1.26e-05	196	116	6	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	343B-Myeloid-Dendritic\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CLEC9A CLEC5A COPS3 SEPTIN6 FCER1A KIFC1	1.30e-05	197	116	6	b340d6f041231e5c69140895aaa1e8d28bafb998
ToppCell	mild-Myeloid-Immature_Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CLEC5A SMC2 GFI1 FANCI DIAPH3 KIFC1	1.30e-05	197	116	6	bd9d57e0c873f6526dca322f4dad8e6bd692586c
ToppCell	(3)_DC_Monocyte_Dividing\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CLEC5A SMC2 FCER1A FANCI DIAPH3 KIFC1	1.34e-05	198	116	6	e2b89f6d7c0007ccab62495cd543fe0e5513a9a4
ToppCell	severe-Myeloid-Immature_Neutrophils_2\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CLEC5A SMC2 GFI1 FANCI DIAPH3 KIFC1	1.34e-05	198	116	6	844f534551483c89ef789d1cfeb4680e54f794b2
ToppCell	severe-Myeloid-Immature_Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CLEC5A SMC2 GFI1 FANCI DIAPH3 KIFC1	1.34e-05	198	116	6	e36303628af3139310c1d7a84d2919b7319bbda4
ToppCell	(5)_Dendritic_cell\|World / shred on Cell_type and subtype	CLEC9A PTGS2 CCDC88A FCER1A CSF3R DIAPH3	1.38e-05	199	116	6	495de74a918c5c625a2d0ef120fe4162d4ce6e76
ToppCell	Mild/Remission-Developping_Plasmablast\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SMC2 GLDC FANCI DIAPH3 IL6R KIFC1	1.38e-05	199	116	6	1dda6116de639140c2d6f5012b7ab9ad0f737ae1
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ZNF195 SMC2 CCDC88A FANCI DIAPH3 KIFC1	1.41e-05	200	116	6	4cfe08878a6981bf7b3567f9e82192d8f060ddde
ToppCell	(52)_cycling_DCs\|World / shred on Cell_type and subtype	CLEC9A CLEC5A PTGS2 FCER1A DIAPH3 KIFC1	1.46e-05	201	116	6	ad2d25d84345fdd593065516a05c5c2b5429eac0
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Slco2a1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CRIM1 FEZF2 NSUN7 LRRC9 DIAPH3	2.58e-05	133	116	5	9d7a08170d38ae9b2ff10a0fa505aeb3aae2824d
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac\|Myeloid_cells / Location, Cell class and cell subclass	DSG3 PNLDC1 NALCN SEPTIN11 FBXL2	3.41e-05	141	116	5	399380de5ea09e22fd128e3e55fffeffc4874c15
ToppCell	severe_COVID-19-cDC\|severe_COVID-19 / disease group, cell group and cell class (v2)	CLEC9A DTNA FCER1A ALPK3 CD200R1L	5.70e-05	157	116	5	ec1978e07e2214048d015d8bb793c1d9991f6e37
ToppCell	droplet-Kidney-nan-3m-Lymphocytic-lymphocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC9A SEPTIN6 CCDC88A DIAPH3 IL6R	6.23e-05	160	116	5	5c28121916a12dbc22ef2421040bdc9148a40b78
ToppCell	droplet-Kidney-nan-3m-Lymphocytic-CD45\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC9A SEPTIN6 CCDC88A DIAPH3 IL6R	6.23e-05	160	116	5	b7093678987575f2f99d648821d31b4a37075aca
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHML GFI1 FBXL2 ZMYM4 ARAP2	6.81e-05	163	116	5	a24db9d266a40f3bffe4f18d277bc269791b4560
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CLEC9A SEPTIN6 CCDC88A ZNF724 KIFC1	7.42e-05	166	116	5	63dc58864268b4e7779e4c45155022556fc634f9
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC9A PARS2 MTOR EPC1 SLC25A19	9.51e-05	175	116	5	bb058e714d21a0ec8532eaf3c7dd2faf78016bc0
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PDE2A COPS3 NAGS CCDC88A FCER1A	9.51e-05	175	116	5	c58a1f02d1e559d3638fe1500e960e82a8a7187b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RELN PDE2A NALCN MICAL2 PRAME	1.00e-04	177	116	5	c274fbdc141855ff4581d437d4997c64cc193278
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RELN PDE2A NALCN MICAL2 PRAME	1.00e-04	177	116	5	f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7
ToppCell	368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	CLEC9A ADAM32 SMC2 DIAPH3 KIFC1	1.00e-04	177	116	5	844017225e9039d1bc621a9630a30c2e9a51b36d
ToppCell	368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CLEC9A ADAM32 SMC2 DIAPH3 KIFC1	1.00e-04	177	116	5	26c25d10aa511b64cc7db43a8deea7b5d31bca96
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RELN PDE2A NALCN MICAL2 PRAME	1.00e-04	177	116	5	c8a51e480b978dc0ded85583261f2c892e085be8
ToppCell	3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho\|lymph-node_spleen / Manually curated celltypes from each tissue	ZNF175 SI PIGU ZNF691 FCER1A	1.00e-04	177	116	5	53040dbeb18574a48e352e4bce252c7c3018762c
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_1\|367C / Donor, Lineage, Cell class and subclass (all cells)	CLEC9A SMC2 FANCI DIAPH3 KIFC1	1.00e-04	177	116	5	ba701d3c90722d8bff70d0fa651899305cdad257
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDE2A CRIM1 MYO10 STRA8 ADGRL4	1.03e-04	178	116	5	a3f95f0002f408b5b6c57e28b297b5b2737e919c
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-lymphatic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	RELN PDE2A ADGRL4 NALCN MICAL2	1.06e-04	179	116	5	ab3d08b51cd7a37582305615ee221c7a2af83b40
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	RELN PDE2A ADGRL4 NALCN MICAL2	1.06e-04	179	116	5	35fe9961e228ce255e3317fc244efa35b5adbf8b
ToppCell	Control-Developping_Plasmablast\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	GLDC FANCI DIAPH3 IL6R KIFC1	1.06e-04	179	116	5	9383568f78b07b8cca72ece5d15fea209aa54ea9
ToppCell	droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DTNA SEPTIN6 LRFN2 ATP1A2 ARAP2	1.09e-04	180	116	5	78fdcfb3fdbf36469cae78407cda5bd0996930d8
ToppCell	Healthy_Control-Lymphoid-T-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	SMC2 FANCI DIAPH3 CD200R1L KIFC1	1.11e-04	181	116	5	ac1ee313910c05b1b3cb497bae14565464919c21
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RELN CRIM1 DTNA LRFN2 NALCN	1.11e-04	181	116	5	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RELN CRIM1 DTNA LRFN2 NALCN	1.11e-04	181	116	5	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	PTGS2 FCER1A HFM1 DIAPH3 KIFC1	1.17e-04	183	116	5	f03d87b556a3d50360d4eb6126b3466fe7266677
ToppCell	COVID-19-B_cells\|COVID-19 / group, cell type (main and fine annotations)	MYO1D SEC24A SEPTIN6 GLDC DIAPH3	1.17e-04	183	116	5	2c016bb59f131a0e821853b085289a3583f0a729
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO1D MICAL2 DIAPH3 TNS1 ARAP2	1.20e-04	184	116	5	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SMC2 FANCI ZNF724 DIAPH3 KIFC1	1.20e-04	184	116	5	6b2449ac65a2322aa0479fba0d89828f243aabbe
ToppCell	343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SMC2 FANCI ZNF724 DIAPH3 KIFC1	1.20e-04	184	116	5	e90622b82fa7f16a1faaf7a4724c958f2d83341d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO1D MICAL2 DIAPH3 TNS1 ARAP2	1.20e-04	184	116	5	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DTNA SMYD2 NALCN ALPK3 MYO18B	1.20e-04	184	116	5	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLEC5A REV3L CHML SLC25A19 IL6R	1.20e-04	184	116	5	b45b1fdba13c8ed2a04a4fb3b62d8ad92785c768
ToppCell	droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PNLDC1 SMC2 FANCM DIAPH3 KIFC1	1.23e-04	185	116	5	0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e
ToppCell	droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PNLDC1 SMC2 FANCM DIAPH3 KIFC1	1.23e-04	185	116	5	89b85ce8026dc80c1bd9f76dfe16401c173b7946
ToppCell	normal-na-Myeloid-conventional_dendritic_cell-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	CLEC9A CCDC88A FCER1A IL6R VDAC1	1.23e-04	185	116	5	67e881a89a491665b8c612fff084c202c0c79235
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GLRA3 PTGS2 CSF3R PNPLA8 IL6R	1.23e-04	185	116	5	42690b95e2e7d56c822211bb1150acb787cfe2e8
ToppCell	10x5'-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic\|lymph-node_spleen / Manually curated celltypes from each tissue	CLEC9A GPR88 CCDC88A DIAPH3 KIFC1	1.23e-04	185	116	5	912d8efdc37820dbb07736221a98af929e5a7c97
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ATP8B3 SMC2 FANCI DIAPH3 KIFC1	1.23e-04	185	116	5	9d424a8608b339dd6129c58d87626678d4ec4af7
ToppCell	COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi\|lung / Disease (COVID-19 only), tissue and cell type	MYO1D SEC24A SEPTIN6 GLDC DIAPH3	1.27e-04	186	116	5	66676d9395172de5707e204826a1c9f73b448cca
ToppCell	COVID_vent-Myeloid-Dendritic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	CLEC9A SI CCDC88A FCER1A IL6R	1.27e-04	186	116	5	63a5cdd3f60681762a218be32db84be8f29b88fd
ToppCell	COVID_vent-Myeloid-Dendritic-cDC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	CLEC9A SI CCDC88A FCER1A IL6R	1.27e-04	186	116	5	39457a7b43537f2c3e221f9375c95d4515424d7d
ToppCell	Dividing_Macrophages-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	ATP8B3 SMC2 FANCI DIAPH3 KIFC1	1.27e-04	186	116	5	0067eb78d4c7e32b9563550d9fcaf13445ee6a48
ToppCell	Healthy-multiplets\|Healthy / disease group, cell group and cell class	CLEC9A MYO1D GLDC DIAPH3 KIFC1	1.27e-04	186	116	5	2ec999b97e95afb898f8083042b0f188d3d234bc
ToppCell	droplet-Fat-SCAT-30m-Endothelial-Cd36+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.33e-04	188	116	5	e901a9bdf00b8e91806f445af66647373bf62661
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO1D PTGS2 MICAL2 FBXL2 ARAP2	1.33e-04	188	116	5	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	droplet-Fat-SCAT-30m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.33e-04	188	116	5	5cf060bb8adaefa9964187195d67993c1248ef47
ToppCell	droplet-Fat-SCAT-30m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.33e-04	188	116	5	449f9602df3c83b2110eb479a00d428d1b55b423
ToppCell	droplet-Fat-Scat-21m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.40e-04	190	116	5	d3e46cf800a07ca9b01c78192962d223b9785d05
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CLEC9A CCDC88A FCER1A IL6R VDAC1	1.40e-04	190	116	5	4b25d49f033bbd326b47cf5602af3f0262cfc367
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.40e-04	190	116	5	38a815abf0ac5cac6071737cadc54a514f62d37d
ToppCell	droplet-Fat-Scat-21m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.40e-04	190	116	5	dd89ef1ecea20b2f6fbdc6cea4ca41b28b3ed822
ToppCell	Monocytes-Tissue-resident_macrophages\|World / Immune cells in Kidney/Urine in Lupus Nephritis	CLEC9A DTNA CLEC5A FCER1A CSF3R	1.40e-04	190	116	5	07215e8f292cb54c670037aaf28393cddbe5548c
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.40e-04	190	116	5	c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073
ToppCell	(2)_Dendritic_Cells\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	CLEC9A CLEC5A PTGS2 FCER1A CSF3R	1.40e-04	190	116	5	5163a5be95fb6c2609bfa3d69166af172f74e724
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.40e-04	190	116	5	5174f91a880f85bb20806023aa68bd4b8ca24ea5
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.40e-04	190	116	5	bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.40e-04	190	116	5	d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.40e-04	190	116	5	90e494cbfbed33a3a0d29bb7dae83f0c81580bcf
ToppCell	3'_v3-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic\|bone_marrow / Manually curated celltypes from each tissue	SMC2 CCDC88A FCER1A DIAPH3 KIFC1	1.43e-04	191	116	5	aa9c0b1b90cdb7a95d4e6332819f82cae0a79ff9
ToppCell	Control-Plasmablast\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MYO1D SEC24A GLDC ARFGAP3 IL6R	1.43e-04	191	116	5	3df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b
ToppCell	wk_20-22-Hematologic-Myeloid-Cycling_DC\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ATP8B3 SMC2 FCER1A DIAPH3 KIFC1	1.43e-04	191	116	5	1da569ebcfab4e1a95315430ae77a17a1f119263
ToppCell	droplet-Fat-Gat-18m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.47e-04	192	116	5	c312e39003c51503c9f648332fb5c6218f33f99b
ToppCell	droplet-Fat-Gat-18m-Endothelial-Cd36+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.47e-04	192	116	5	df09056f0e562f53b6fb30b674d2d83e9eb857d0
ToppCell	droplet-Fat-Gat-18m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.47e-04	192	116	5	133b3ad251d72ff31e45e1dc6217945516ac63de
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RELN SMYD2 CCDC88A MICAL2 TNS1	1.47e-04	192	116	5	d43caf42ec744e895137f31ef65a990e250669d2
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CLEC9A CCDC88A FCER1A IL6R VDAC1	1.47e-04	192	116	5	8e606eae3e5b07a856d3c2a74186d486da96309c
ToppCell	control-Myeloid-Immature_Neutrophils_2\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CLEC5A GFI1 FANCI DIAPH3 KIFC1	1.50e-04	193	116	5	33349830e9eba506470ad3661fad5e5a283d20ca
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	CRIM1 MYO1D MYO10 DTNA NALCN	1.50e-04	193	116	5	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	SMC2 OPCML FANCI DIAPH3 KIFC1	1.50e-04	193	116	5	516ea2c12bdc7a5dc676159d627e36f6abe13ef0
ToppCell	Fetal_brain-fetalBrain_Zhong_nature\|Fetal_brain / Sample Type, Dataset, Time_group, and Cell type.	DSG3 JADE1 SEPTIN6 SEPTIN11 ZNF84	1.50e-04	193	116	5	1553c856f3b71c1b0a78ec8d59c7948144d9c5bb
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF195 IGSF5 ZNF621 COPS3 ZNF691	1.50e-04	193	116	5	088c8b1e968f5356502347eaabdc6b1b1d4befd0
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATP8B3 CCDC88A FANCI DIAPH3 KIFC1	1.54e-04	194	116	5	e5b81a8e52259a54a911c1c2ac932c98c988318d
ToppCell	PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYO1D SMC2 GLDC DIAPH3 KIFC1	1.54e-04	194	116	5	5a519538327029ad2b880ef9647e2ac6ab3961a4
ToppCell	droplet-Fat-Scat-18m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.54e-04	194	116	5	0f81df418166589ea327d6dfe06674bcf2fe8f72
ToppCell	droplet-Fat-Scat-18m-Endothelial-Cd36+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.54e-04	194	116	5	009b005a94a5c80f6e1fdda2a0c7881a9a0ce75b
ToppCell	droplet-Fat-Scat-18m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CRIM1 MYO10 ADGRL4 TNS1	1.54e-04	194	116	5	84bfe5e68069824370dc2a3f2c5958c552eaaa03
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	DTNA SMYD2 NALCN ALPK3 MYO18B	1.58e-04	195	116	5	f1ef50331eda8f1239dba6ea970df4eaccf032f1
Disease	Large cell carcinoma of lung	ATR MTOR ALPK3 MYO18B	6.75e-06	32	113	4	C0345958
Disease	glomerular filtration rate, renal transplant outcome measurement	GLRA3 OR1D4 MICAL2 OR1D5	9.74e-06	35	113	4	EFO_0005199, EFO_0005208
Disease	severe congenital neutropenia (implicated_via_orthology)	GFI1 CSF3R	4.35e-05	3	113	2	DOID:0050590 (implicated_via_orthology)
Disease	myelodysplastic syndrome (is_marker_for)	GFI1 CSF3R PRAME	5.94e-05	20	113	3	DOID:0050908 (is_marker_for)
Disease	glioblastoma (biomarker_via_orthology)	PTGS2 ADGRL4	8.68e-05	4	113	2	DOID:3068 (biomarker_via_orthology)
Disease	rheumatoid arthritis	PDE2A PTGS2 GFI1 SENP1 EXOC2 CD200R1L IL6R VDAC1	4.15e-04	462	113	8	EFO_0000685
Disease	rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement	PTGS2 GFI1 EXOC2 CD200R1L IL6R	5.09e-04	170	113	5	EFO_0000685, EFO_0007791, EFO_0007837
Disease	Malignant Head and Neck Neoplasm	FANCM FANCI PRAME	6.46e-04	44	113	3	C0278996
Disease	niacinamide measurement	SEPTIN8 EXOC2	9.36e-04	12	113	2	EFO_0010511
Disease	Congenital neutropenia	GFI1 CSF3R	9.36e-04	12	113	2	C0340970
Disease	Sarcomatoid Renal Cell Carcinoma	PTGS2 MTOR PRAME IL6R	1.51e-03	128	113	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	PTGS2 MTOR PRAME IL6R	1.51e-03	128	113	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	PTGS2 MTOR PRAME IL6R	1.51e-03	128	113	4	C1266044
Disease	Papillary Renal Cell Carcinoma	PTGS2 MTOR PRAME IL6R	1.51e-03	128	113	4	C1306837
Disease	Renal Cell Carcinoma	PTGS2 MTOR PRAME IL6R	1.51e-03	128	113	4	C0007134
Disease	Global developmental delay	INTS1 TRMT1 PIGU CSDE1	1.74e-03	133	113	4	C0557874
Disease	Bone marrow hypocellularity	FANCM FANCI	2.14e-03	18	113	2	C1855710
Disease	MYELODYSPLASTIC SYNDROME	FANCM CSF3R FANCI	2.19e-03	67	113	3	C3463824
Disease	portal hypertension (implicated_via_orthology)	PTGS2 MTOR	2.38e-03	19	113	2	DOID:10762 (implicated_via_orthology)
Disease	bipolar disorder (is_marker_for)	RELN PTGS2	2.38e-03	19	113	2	DOID:3312 (is_marker_for)
Disease	emphysema pattern measurement	MYO1D SEPTIN11	2.38e-03	19	113	2	EFO_0005850
Disease	anorexia nervosa	MYO1D OPCML ADGRL4	2.48e-03	70	113	3	MONDO_0005351
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	PTGS2 MTOR PRAME IL6R	2.56e-03	148	113	4	C0279702
Disease	status epilepticus (implicated_via_orthology)	PTGS2 MTOR	2.91e-03	21	113	2	DOID:1824 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
ACFSAKVNNSSLIGL	VDAC1	231	P21796
INTNTNKLFCSIIAG	ADGRL4	481	Q9HBW9
GFSAQQVATQATAKT	ARNT	646	P27540
NCFTKGQKNSTLIFT	C21orf62	21	Q9NYP8
SSALKLAAAANCQVS	EPC1	786	Q9H2F5
IFKGENVTLTCNGNN	FCER1A	41	P12319
SLGAQKLANTCFNEI	ARFGAP3	231	Q9NP61
TLFSQVQLFISTCNG	COPS3	76	Q9UNS2
VANNSISCNRQSGVK	FBXO10	771	Q9UK96
IYQASAQNSKGIVSC	ALPK3	351	Q96L96
STNCSRLQNKVSGKF	ABITRAM	71	Q9NX38
SVKFQLCVLGQNAQT	CSDE1	651	O75534
SFQNFISNVGVKCLQ	ADAM32	366	Q8TC27
LVFSSCLFQTKGQTS	ARAP2	1266	Q8WZ64
KTGTLTQNILTFNKC	ATP8B3	496	O60423
CQVAKSNSQTNGLNF	CCDC180	1131	Q9P1Z9
NAQTFGFNLSSLCKL	DIAPH3	856	Q9NSV4
KCFSLGVNLQNVAES	CC2D2B	121	Q6DHV5
CTTIDGLNATKNFLQ	CHML	351	P26374
GNIISGDKTISFNNC	OR6C1	81	Q96RD1
ALCQLGKYTTNNSSE	RARA	201	P10276
NVTCNIFINSFGSIA	GLRA3	71	O75311
NLSGNQICSFKELTN	LRRC9	171	Q6ZRR7
QQTGFVKCQTLSGSQ	DSG3	891	P32926
NFKVLGSLSSSQCSQ	FANCI	546	Q9NVI1
QSTSIGIKNNICAFL	FANCI	731	Q9NVI1
VGDSSLKTFAQNCRN	FBXL2	91	Q9UKC9
KLQTTSNAFIVNGCA	GPR88	61	Q9GZN0
FFTVNACLNGSQLAV	IL17RD	11	Q8NFM7
QVCGKAFSQSSNLIT	GFI1	371	Q99684
FKAKGNSLVSVLACN	INTS1	196	Q8N201
NFASKNIFGVQLTAS	DOP1B	636	Q9Y3R5
SFIKNINQGSSSSVI	FANCM	816	Q8IYD8
QNCTFVIQANGTVLA	HERC1	4036	Q15751
FASKVNQCVIGTAQA	KIFC1	656	Q9BW19
TVNSSAGFRSKQLVN	CCDC88A	1541	Q3V6T2
FQSRNITAVCKAVTG	CD200R1L	151	Q6Q8B3
QCVSSFSKNGALQAR	EXOC2	841	Q96KP1
QTSTLLCFSVNGVFK	NXF1	486	Q9UBU9
RGTNNSFQVASKSVL	PDE2A	701	O00408
NNSSRFGKFVQLNIC	MYO10	216	Q9HD67
NTASIQSLICNNVKG	PTGS2	546	P35354
EVLKCQQGVSSLAFA	NAGS	146	Q8N159
AKSTCAINNTLIAFF	PIGU	156	Q9H490
LQFKLNIGCANQFSS	RELN	1301	P78509
LVFCATRKGVQQAAS	HFM1	531	A2PYH4
CVATNKLGNTNASIT	OPCML	296	Q14982
LTQNKFITYAGCLSQ	OR7C1	86	O76099
CNRAVFKAGQENISV	ATP1A2	426	P50993
VTVLLKGCQDANSQA	ATR	1336	Q13535
LKGSQARFNCTVSQG	IGSF5	51	Q9NSI5
KFSKTQTFQGCGILQ	IL6R	201	P08887
SLNNQLVSVDCKKGT	CRIM1	981	Q9NZV1
FTLKSFKSRGNCQTQ	CSF3R	156	Q99062
VNVTCNIFINSFGSV	GLRA2	71	P23416
SCFSQQKKVTLNGFL	DTNA	196	Q9Y4J8
RALQATVGNSYKCNA	LAMP1	326	P11279
LIICLVNNKGSANSS	DYNAP	131	Q8N1N2
AFIAQALCLQGKSTS	FAM120B	741	Q96EK7
NQCGKAFNRSSTLNT	FEZF2	336	Q8TBJ5
QASTCKGTLQAFNIL	MICAL2	21	O94851
LAKNKSISFIGCATQ	OR5T3	116	Q8NGG3
SGQNKTQGFRKAISC	PHYH	266	O14832
QSQNKAISYAGCLTQ	OR1D4	86	P47884
QSQNKAISYAGCLTQ	OR1D5	86	P58170
LSSQKTIIFSGCAVQ	OR2K2	86	Q8NGT1
SSNVSVLQQFASGLK	MTOR	16	P42345
STLNSVSKAVFGNQN	PNPLA8	106	Q9NP80
FNAQFTNVCGKPTLA	PARS2	321	Q7L3T8
LRVASQNKFGQFCTV	PMPCA	76	Q10713
KASASKQALVFQCVG	TRMT1	336	Q9NXH9
LQTEGSQCAKTFINL	ATP6V1H	66	Q9UI12
LVNKSTSQGFCFNIL	SEPTIN11	31	Q9NVA2
AQFTSQFLSLQCLQA	PRAME	286	P78395
QTNSKGSSNFCVKNI	AHCYL1	96	O43865
VGKNCTQNFLSQVLG	SEC24A	996	O95486
SILTNNNTSKVFVCG	NSUN7	311	Q8NE18
QQFTVCQIGLSVFSA	PNLDC1	51	Q8NA58
KDSLFKNGNSCASQI	SENP1	231	Q9P0U3
SFIQGSTKGCNVNKL	SI	511	P14410
CNGSLIKVNYNQTAV	JADE1	721	Q6IE81
QLVNKSVSQGFCFNI	SEPTIN6	31	Q14141
SACKSLQTRQNGIQT	STX5	66	Q13190
GLSCANTQVKQEASF	STRA8	296	Q7Z7C7
AKNQAVAQSSGSYLC	B3GNTL1	96	Q67FW5
NQNFNCATIGLTKTF	CLEC5A	156	Q9NY25
SANQVCGYVKSNSLL	CLEC9A	206	Q6UXN8
TKANQTSVGCTQLVL	CDK5RAP1	511	Q96SZ6
QKGVNNGVYQCLSTT	ZNF595	126	Q8IYB9
NGVYQCLSTTQSKIF	ZNF595	131	Q8IYB9
NGLNQCLTTTDSKIF	ZNF92	131	Q03936
VQCGKGFTQSSNLIT	ZNF436	421	Q9C0F3
NGFNQCLTTTQSKIF	ZNF724	131	A8MTY0
ICAQCGKTFNNTSNL	ZNF691	116	Q5VV52
GFNGLNQCLKITTSK	ZNF138	66	P52744
INAQQKLSGCFSSFL	REV3L	1286	O60673
ANSTADLLKQGAACN	TNS1	1586	Q9HBL0
SKSVTQGFSFNILCV	SEPTIN8	36	Q92599
STVARFTQCQNGKIS	SMC2	1166	O95347
SNCGKSFISKSQLQV	ZNF585A	301	Q6P3V2
VSQSIVLFQAACKGF	MYO18B	1336	Q8IUG5
SQCGKAFSQKSQLTS	ZNF84	266	P51523
CGKAFTQKIASIQHQ	ZNF621	296	Q6ZSS3
NGLNQCLTATQSKVF	ZNF90	131	Q03938
QGTLTTFFNLCNKID	ZMYM6	1131	O95789
FTLTSANVGKCQTVL	PHLPP1	1281	O60346
QTNLSGKCAQLGFSQ	TOGARAM1	741	Q9Y4F4
DNQKLSCVISSVGAN	SUDS3	281	Q9H7L9
SLVVLFAQVNCNGFT	SMYD2	171	Q9NRG4
RNNTKFQVAVAGSVS	SLC25A19	11	Q9HC21
NTNSLGKTELFCSVN	ZMYM4	546	Q5VZL5
SCVVAFQNLFNKPTG	ZMYM4	606	Q5VZL5
ECGKNFTQSSNLIVH	ZNF195	526	O14628
GLNQCFTTAQSKVFQ	ZNF254	141	O75437
CGKGFSQNSTLIIHQ	ZNF175	396	Q9Y473
QFVLTAGCAADQAKQ	UBALD1	16	Q8TB05
KATSNICTAQALLAN	GLDC	376	P23378
ASNKAFVVNNLVSGT	LRFN2	471	Q9ULH4
DCNGIFRINVSVSKN	NALCN	1056	Q8IZF0
SNCVLEAFGNAKTNR	MYO1D	141	O94832